The Evolution of Extensively Drug Resistant Tuberculosis (XDR-TB): History, Status and Issues for Global Control

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 7, Iss. 2, 2007-06 ,pp. : 73-91

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical Pharmacology and Lesion Penetrating Properties of Second- and Third-Line Antituberculous Agents Used in the Management of Multidrug-Resistant (MDR) and Extensively-Drug Resistant (XDR) Tuberculosis

By  

Current Clinical Pharmacology, Vol. 5, Iss. 2, 2010-05 ,pp. : 96-114

Bentham Science Publishers

Access to resources Recommend Favorite

Ensure a comprehensive approach when treating drug-resistant tuberculosis

By  

Drugs & Therapy Perspectives, Vol. 28, Iss. 3, 2012-03 ,pp. : 15-18

Adis International

Access to resources Recommend Favorite

Comparison of the Pharmacokinetics of Two Dosage Regimens of Linezolid in Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis Patients

By Alffenaar Jan-Willem C.  

Clinical Pharmacokinetics, Vol. 49, Iss. 8, 2010-08 ,pp. : 559-565

Adis International

Access to resources Recommend Favorite

Multidrug-resistant TB gets backing from drug giant

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 416, 2003-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite